Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
Clinical trial NCT02888054 · COMPLETED
Trial details
- NCT number
- NCT02888054
- Sponsor
- Ardea Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2016-10-18
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.